← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Protease inhibitors
amprenavir
J05AE05
Forms & Strengths
- Capsules: 50mg, 150mg
- Oral solution: 15mg/mL
Adult Dosing
- 1500mg twice daily
- 1200mg twice daily with ritonavir
Pediatric Dosing
- 20mg/kg twice daily or 15mg/kg three times daily
- 14-18 years: 1200mg twice daily with ritonavir
Indications
- HIV-1 infection
- Treatment of HIV-1 in combination with other antiretrovirals
Mechanism of Action
- Inhibits the HIV-1 protease enzyme
- Prevents the maturation of the virus
Contraindications
- Hypersensitivity to amprenavir
- Concurrent use of ritonavir in patients with renal or hepatic impairment
- Concurrent use of ergot derivatives, cisapride, or pimozide
Adverse Reactions
- Nausea
- Vomiting
- Diarrhea
- Fatigue
- Headache
- Rash
Drug Interactions
- Ritonavir: increases amprenavir levels
- Rifampin: decreases amprenavir levels
- Ketoconazole and itraconazole: increases amprenavir levels
- Ergot derivatives, cisapride, and pimozide: potentially life-threatening interactions
Curated Content: Needs Vetting Before Put to Clinical Use